Thanks, that does imply that efficacy can complete the trial. However, would you still have to monitor for 24 weeks during which time the trial proceeds to subsequent cohorts?
Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat